You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API fingolimod hcl

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing fingolimod hcl

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	GILENYA	fingolimod hcl	0078-0607	FERRIC OXIDE YELLOW
Novartis Pharmaceuticals Corporation	GILENYA	fingolimod hcl	0078-0607	GELATIN
Novartis Pharmaceuticals Corporation	GILENYA	fingolimod hcl	0078-0607	MAGNESIUM STEARATE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing fingolimod hcl

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Rising Pharma Holdings Inc	fingolimod hcl	64980-449	FERROSOFERRIC OXIDE
Rising Pharma Holdings Inc	fingolimod hcl	64980-449	GELATIN
Rising Pharma Holdings Inc	fingolimod hcl	64980-449	MAGNESIUM STEARATE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for fingolimod hcl

Excipient focus: FERRIC OXIDE YELLOW

fingolimod hcl drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

fingolimod hcl drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
>Company	>Ingredient	>NDC

Excipient focus: GELATIN

fingolimod hcl drug variants containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

fingolimod hcl drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

fingolimod hcl drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

Excipient focus: POTASSIUM HYDROXIDE

fingolimod hcl drug variants containing POTASSIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing POTASSIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
>Company	>Ingredient	>NDC

Excipient focus: SHELLAC

fingolimod hcl drug variants containing SHELLAC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing SHELLAC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
>Company	>Ingredient	>NDC

Excipient focus: STARCH, CORN

fingolimod hcl drug variants containing STARCH, CORN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing STARCH, CORN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

fingolimod hcl drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	fingolimod hcl	0078-0607
Rising Pharma Holdings Inc	fingolimod hcl	64980-449
>Company	>Ingredient	>NDC

fingolimod hcl drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.